Abstract
Angiogenesis, also known as new blood vessel formation, is a critical process during physiological and pathological conditions (1,2). During normal development, the physiological wound healing process, and the female menstrual cycle, blood vessel growth is coordinated concomitantly with tissue growth. However, during pathological processes such as solid cancer development, diabetic retinopathy, rheumatoid arthritis, and psoriasis, abnormal angiogenesis contributes to disease progression. Thus, much effort is directed toward understanding of and the control of the angiogenesis process (3). Angiogenesis involves the orderly migration, proliferation, and differentiation of vascular endothelial cells into nascent blood vessel sprouts. This is followed by vascular stabilization, which entails the coverage with mural cells (pericytes or vascular smooth muscle cells) (4). Numerous factors regulate the various phases of angiogenesis. A major regulator of angiogenesis, vascular endothelial growth factor (VEGF), was upregulated in tumor angiogenesis, and inhibition of this factor with a specific monoclonal antibody was recently approved for clinical use in colorectal cancer (3). However, angiogenesis is regulated by multiple redundant pathways; therefore, multiple approaches might be needed to effectively control angiogenesis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Risau, W. (1997) Mechanisms of angiogenesis. Nature 386, 671–674.
Ferrara, N., Gerber, H. P., and LeCouter, J. (2003) The biology of VEGF and its receptors. Nat. Med. 9, 669–676.
Ferrara, N., Hillan, K. J., Gerber, H. P., and Novotny, W. (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat. Rev. Drug Discov. 3, 391–400.
Jain, R. K. (2003) Molecular regulation of vessel maturation. Nat. Med. 9, 685–693.
Hla, T. (2001) Sphingosine 1-phosphate receptors. Prostaglandins 64, 135–142.
Hla, T. and Maciag, T. (1990) An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to Gprotein-coupled receptors. J. Biol. Chem. 265, 9308–9313.
Allende, M. L., Yamashita, T., and Proia, R. L. (2003) G-Protein-coupled receptor S1P acts within endothelial cells to regulate vascular maturation. Blood 102, 3665–3667.
Chae, S. S., Paik, J-H., Furneaux, H., and Hla, T. (2004) Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J. Clin. Invest., in press.
Lee, M. J., Thangada, S., Paik, J. H., et al. (2001) Akt-Mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol. Cell 8, 693–704.
Hannon, G. J. (2002) RNA interference. Nature 418, 244–251.
Elbashir, S. M., Lendeckel, W., and Tuschl, T. (2001) RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes Dev. 15, 188–200.
Song, E., Lee, S. K., Wang, J., et al. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9, 347–351.
Rubinson, D. A., Dillon, C. P., Kwiatkowski, A. V., et al. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33, 401–406.
Dave, R. S. and Pomerantz, R. J. (2003) RNA interference: on the road to an alternate therapeutic strategy! Rev. Med. Virol. 13, 373–385.
Amarasinghe, A. K., Calin-Jageman, I., Harmouch, A., Sun, W., and Nicholson, A. W. (2001) Escherichia coli ribonuclease III: affinity purification of hexahistidinetagged enzyme and assays for substrate binding and cleavage. Methods Enzymol. 342, 143–158.
Yang, D., Buchholz, F., Huang, Z., et al. (2002) Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 99, 9942–9947.
Liu, C. H. and Hla, T. (1997) The mouse gene for the inducible G-protein-coupled receptor edg-1. Genomics 43, 15–24.
Paik, J. H., Chae, S., Lee, M. J., Thangada, S., and Hla, T. (2001) Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3-and beta1-containing integrins. J. Biol. Chem. 276, 11,830–11,837.
Ancellin, N., Colmont, C., Su, J., et al. (2002) Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J. Biol. Chem. 277, 6667–6675.
Acknowledgments
The authors thank Dr. Allan Nicholson for the gift of the RNase III plasmid, and Dr. Henry Furneaux and Dr. Ji-Hye Paik for helpful discussions.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Chae, SS., Hla, T. (2005). Inhibition of Gene Expression In Vivo Using Multiplex siRNA. In: Carmichael, G.G. (eds) RNA Silencing. Methods in Molecular Biology™, vol 309. Humana Press. https://doi.org/10.1385/1-59259-935-4:197
Download citation
DOI: https://doi.org/10.1385/1-59259-935-4:197
Publisher Name: Humana Press
Print ISBN: 978-1-58829-436-4
Online ISBN: 978-1-59259-935-6
eBook Packages: Springer Protocols